Proliferation of human hematopoietic bone marrow cells in simulated microgravity.
Expansion and/or maintenance of hematopoietic stem cell (HSC) potential following in vitro culture remains a major obstacle in stem cell biology and bone marrow (BM) transplantation. Several studies suggest that culture of mammalian cells in microgravity (micro-g) may reduce proliferation and differentiation of these cells. We investigated the application of these findings to the field of stem cell biology in the hopes of expanding HSC with minimal loss of hematopoietic function. To this end, BM CD34+ cells were cultured for 4-6 d in rotating wall vessels for simulation of micro-g, and assessed for expansion, cell cycle activation, apoptosis, and hematopoietic potential. While CD34+ cells cultured in normal gravity (1-g) proliferated up to threefold by day 4-6, cells cultured in micro-g did not increase in number. As a possible explanation for this, cells cultured in simulated micro-g were found to exit G0/G1 phase of cell cycle at a slower rate than 1-g controls. When assayed for primitive hematopoietic potential in secondary conventional 1-g long-term cultures, cells from initial micro-g cultures produced greater numbers of cells and progenitors, and for a longer period of time, than cultures initiated with 1-g control cells. Similar low levels of apoptosis and adhesion molecule phenotype in micro-g and 1-g-cultured cells suggested similar growth patterns in the two settings. These data begin to elucidate the effects of micro-g on proliferation of human hematopoietic cells and may be potentially beneficial to the fields of stem cell biology and somatic gene therapy.
Plett
P A
PA
Indiana Elks Cancer Research Center, Department of Medicine, Indiana University School of Medicine, Indianapolis 46202, USA. pplett@iupui.edu
Frankovitz
S M
SM
Abonour
R
R
Orschell-Traycoff
C M
CM
D018952:Antigens, CD34 / Q000032:analysis; D017209:Apoptosis; D001854:Bone Marrow Cells / Q000166:cytology* / Q000276:immunology; D015815:Cell Adhesion Molecules / Q000032:analysis; D002453:Cell Cycle; D002455:Cell Division; D002478:Cells, Cultured; D006410:Hematopoiesis; D006412:Hematopoietic Stem Cells / Q000166:cytology* / Q000276:immunology; D006801:Humans; D007377:Interleukin-3 / Q000494:pharmacology; D015850:Interleukin-6 / Q000494:pharmacology; D019089:Stem Cell Factor / Q000494:pharmacology; D013926:Thrombopoietin / Q000494:pharmacology; D018474:Weightlessness Simulation
D018952:Antigens, CD34; D015815:Cell Adhesion Molecules; D007377:Interleukin-3; D015850:Interleukin-6; D019089:Stem Cell Factor; D013926:Thrombopoietin